NCT02941289

Brief Summary

The aim is to understand which components of attentional deployment and selection are impaired in AD during searching in realistic scenes on a computer screen (Experiment 1) and in a natural setting (Experiment 2).The investigators will also examine how deficits in visual exploration may be related to impairments in semantic, long-term memory (LTM) and working memory (WM) representations by manipulating the semantic consistency between the target and its visual surroundings, and the type of target cue (abstract vs. precise), respectively. Perceptual saliency of target and distractor objects will be also manipulated in Expt.1, In Expt.2, in order to determine how deficits in visual exploration may be involved in the IADL deficits shown by AD patients, participants at each trial will be required to search in a natural settings different types of targets and then to perform an IADL using five objects, among which one of the searched targets. Measures analysed: for the search tasks (Expt. 1 and 2): eye movements in different search phases, accuracy and response times; for IADLs tasks (Expt. 2): eye movements during action planning and execution, motor efficiency (number and types of action performed), time to terminate the activity. Compared to controls, the investigators expect that AD patients will have reduced ability using scene semantic LTM in order to locate the objects, greater attentional capture from highly salient features and greater search performance impairment when higher WM resources are required (abstract target cues). The investigators also expect that their performance at IADLs will be less efficient and, in particular, less organized than control, with reduced advantage of eye guidance.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 30, 2016

Completed
5 months until next milestone

First Posted

Study publicly available on registry

October 21, 2016

Completed
6 months until next milestone

Study Start

First participant enrolled

April 27, 2017

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 12, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 12, 2018

Completed
Last Updated

March 24, 2026

Status Verified

March 1, 2026

Enrollment Period

12 months

First QC Date

May 30, 2016

Last Update Submit

March 20, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Total number of fixations during search

    Oculomotor behavior and search performance in AD patients compared to elderly controls in a computerized visual search task using realistic scenes (Experiment 1), as well as when searching for specific objects in a real setting and during activities of daily living (Experiment 2).

    at 2 weeks

  • Total duration of fixations during search

    This is the eye movement parameters that the investigators will analyze in the data

    at 2 weeks

Study Arms (2)

Alzheimer's patient

EXPERIMENTAL

Probable diagnosis of Alzheimer's disease with a mild impairment (MMSE 20-26) according to DSM IV diagnosis criteria

Procedure: Performance of everyday objects in realistic scenes

Control patient

ACTIVE COMPARATOR

patient with MMSE score equal or \> 27

Procedure: Performance of everyday objects in realistic scenes

Interventions

visual search performance of everyday objects in realistic scenes

Alzheimer's patientControl patient

Eligibility Criteria

Age65 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

You may qualify if:

  • Male and female
  • Age between 65 and 75 years old
  • MMSE score equal or \> 27
  • Normal visual acuity (with or without correction to normality)
  • Subjects with a score of 0 on " tremors " and " rigidity " items of UPDRS III scale
  • Subjects without major depression criteria according to DSM IV-R
  • No apathy according to diagnostic criteria of apathy
  • Signed informed consent
  • Male and female
  • Age between 65 and 75 years old
  • Probable diagnosis of Alzheimer's disease with a mild impairment (MMSE 20-26) according to DSM IV diagnosis criteria
  • Normal visual acuity (with or without correction to normality)
  • Subjects with a zero score on " tremors " and " rigidity " items of UPDRS III scale
  • Signed informed consent

You may not qualify if:

  • Controls with neurological and/or psychiatric pathologies
  • AD patients with neurological and/or psychiatric pathologies unrelated to AD
  • AD patients with vascular dementia suspicion in addition to the probable diagnosis of AD
  • AD patients with MMSE score \< 20
  • Individuals with abnormal visual acuity (i.e., glaucoma, cataract sufficiently severe that limited vision…)
  • Individuals with motor disorders, Parkinsonism…
  • Receiving drug treatments that could alter cognitive functions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de Nice

Nice, France

Location

Related Publications (2)

  • Ramzaoui H, Faure S, David R, Spotorno S. Top-down and bottom-up sources of eye-movement guidance during realistic scene search in Alzheimer's disease. Neuropsychology. 2022 Oct;36(7):597-613. doi: 10.1037/neu0000797. Epub 2022 Jul 7.

  • Ramzaoui H, Faure S, Spotorno S. Top-down and bottom-up guidance in normal aging during scene search. Psychol Aging. 2021 Jun;36(4):433-451. doi: 10.1037/pag0000485.

MeSH Terms

Conditions

Alzheimer Disease

Condition Hierarchy (Ancestors)

DementiaBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesTauopathiesNeurodegenerative DiseasesNeurocognitive DisordersMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 30, 2016

First Posted

October 21, 2016

Study Start

April 27, 2017

Primary Completion

April 12, 2018

Study Completion

April 12, 2018

Last Updated

March 24, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations